
Pharmaceuticals & Healthcare · BSE
Incorporated in 2007, Shelter Pharma Limited (formerly Shelter Pharmacy) manufactures herbal products for human and veterinary healthcare. Headquartered in Himmatnagar, Gujarat, the company focuses on providing cost-effective and high-quality solutions for human, poultry, and animal health. Its human healthcare products include Lemonade Barley Water, Sherolax, Baldeepak, and Stonyl Tablets, while veterinary offerings include Agrical Powder, Lactocal Gel, and Shelodex Ultra Ointment. Shelter Pharma combines Ayurvedic principles with modern practices to develop its range of health supplements. The company primarily serves rural and semi-urban markets, delivering accessible herbal healthcare solutions across India.
Price Band
₹42
Issue Size
₹16.03 Cr
Lot Size
3000 shares
GMP
Est. Listing
₹42
at current GMP
Subscribed
15.25x
overall
Open
10 Aug 2023
Close
14 Aug 2023
Allotment
18 Aug 2023
Refund
19 Aug 2023
Demat Credit
20 Aug 2023
Listing
23 Aug 2023
Last updated: 19 Oct 2026
Current Premium
Issue Price (Upper)
₹42
Band: ₹42
Estimated Listing Price
₹42
Upper price + GMP
Lot Size
3000 shares
Min investment ₹1,26,000
Estimated Profit / Lot
₹0
3000 × ₹0
Grey Market Premium trend
—
▲ 0 today
Updated less than a minute ago
| Date | GMP (₹) | GMP % | Est. Listing |
|---|---|---|---|
| 31 Oct 2026 | — | 0.0% | ₹42 |
| 30 Oct 2026 | — | 0.0% | ₹42 |
| 29 Oct 2026 | — | 0.0% | ₹42 |
GMP is unofficial market data. Not a guarantee of listing performance.
Shelter Pharma Limited is bringing an initial public offering (IPO) in the Pharmaceuticals & Healthcare sector with an aggregate issue size of ₹16.03 Crores. The shares are offered at a price band of ₹42 to ₹42 per equity share on BSE. Currently, grey market participants and retail investors are watching the bidding trend, premium movement, and anchor book demand with keen interest.
Prospective investors can apply in the retail quota with a minimum of 1 lot comprising 3000 shares (approx. ₹1,26,000 minimum investment). High net-worth individuals (HNI/NII) can bid in the sHNI (₹2 Lakh to ₹10 Lakh) or bHNI (above ₹10 Lakh) categories for enhanced quota allocation.
Allotment reconciliation will be managed by Bigshare Services Private Limited. Eligible allottees will receive credit of equity shares into their Demat accounts by 2023-08-20, while un-allotted funds or UPI block mandates will be released on 2023-08-19.
The latest grey market premium for Shelter Pharma Limited IPO is ₹0, which indicates an expected listing price of ₹42.
Kostak rate is the profit amount an investor earns by selling their entire IPO application in the grey market before allotment is finalized.
No. GMP is an unofficial indicator discovered between dealers outside of SEBI-regulated exchanges. Actual listing price is determined by demand-supply discovery on NSE/BSE during the pre-open auction.